SCHEMBL10109720

SCHEMBL10109720

Cc1cn(C2C=CC(CO)C2)c(=O)nc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 5/20 0.41
NR1I2 O75469 1/20 0.41
PDE4D Q08499 1/20 0.41
ADCY5 O95622 6/20 0.36
DNMT1 P26358 3/20 0.33
ADRB1 P08588 1/20 0.33
EP300 Q09472 1/20 0.31
LMNA P02545 3/20 0.31
CACNA1F O60840 2/20 0.31
MAPT P10636 2/20 0.31
CACNA1D Q01668 2/20 0.31
CACNA1S Q13698 2/20 0.31
CACNA1C Q13936 2/20 0.31
PDE3A Q14432 2/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
ADRA1A P35348 1/20 0.31
BLM P54132 1/20 0.31
TK1 P04183 1/20 0.31
ABCB1 P08183 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10123433 0.84 ALB (0.53) ALBNR1I2PDE4DADCY5
SCHEMBL8885064 0.82 ALB (0.32) ALBDNMT1ADRB1
SCHEMBL9220438 0.80 ALB (0.40) ALBDNMT1ADRB1LMNACACNA1F
SCHEMBL28741406 0.78 ALB (0.37) ALBNR1I2PDE4DADCY5DNMT1
SCHEMBL15046170 0.77 LMNA (0.50) ALBNR1I2PDE4DADCY5DNMT1
SCHEMBL24839531 0.75 TK1 (0.47) ALBDNMT1ADRB1LMNAALDH1A1
SCHEMBL21275614 0.74 AHCY (0.49) ALBDNMT1ADRB1
SCHEMBL16629489 0.74 AHCY (0.49) ALBDNMT1ADRB1
SCHEMBL28741392 0.73 ALB (0.36) ALBNR1I2PDE4DADCY5
SCHEMBL20059119 0.73 ALB (0.40) ALBDNMT1ADRB1LMNACACNA1F

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9861652-B2 2′ Fluoronucleosides EMORY UNIVERSITY (US) 2018-01-09 US disclosed
US-20160158266-A1 2' FLUORONUCLEOSIDES EMORY UNIVERSITY 2016-06-09 US disclosed
US-9180138-B2 2′-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2015-11-10 US disclosed
US-20130157971-A1 2'-FLUORONUCLEOSIDES SCHINAZI RAYMOND F (US) 2013-06-20 US disclosed
US-8168583-B2 2-fluoronucleosides UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-05-01 US disclosed
US-20100173863-A1 2-Fluoronucleosides NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-07-08 US disclosed
US-7662938-B2 2′-fluoronucleosides EMORY UNIVERSITY (US) 2010-02-16 US disclosed
US-20080300398-A1 2'-FLUORONUCLEOSIDES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173863-A1 2-Fluoronucleosides PNP, BCL3, NPC1 ALB 2753/4885NR1I2 2587/4885PDE4D 2010/4885
US-20080300398-A1 2'-FLUORONUCLEOSIDES METTL3, BCL3, PNP ALB 2185/4885NR1I2 2396/4885PDE4D 2333/4885
US-20160158266-A1 2' FLUORONUCLEOSIDES PNP, BCL3, NPC1 ALB 2635/4885NR1I2 2595/4885PDE4D 2039/4885
US-20130157971-A1 2'-FLUORONUCLEOSIDES PNP, BCL3, FUBP3 ALB 2527/4885NR1I2 2669/4885PDE4D 2036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.